This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on August 22, 2022 and assigned serial number 90864376 by the TTAB.

Plaintiff:
Prime Therapeutics LLC represented by MOLLY T. EICHTEN of LARKIN HOFFMAN DALY & LINDGREN LTD..

Defendant:
AESOP Technology Inc. represented by CHINHWEI CHEN of JIANQ CHYUN INTELLECTUAL PROPERTY OFFICE.
Trademark Information: RX PRIME – US Trademark Serial Number 90864376
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
August 22, 2022 – FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE
August 22, 2022 – EXT GRANTED
September 21, 2022 – ADD’L 60-DAY REQUEST TO EXT TIME TO OPPOSE
September 21, 2022 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.